The prime time of investment in TECHNOLOGY sector, namely computer/network/inter... personal devices and enterprise software(ERP) was long gone.
The next big thing coming is stem cell based regenerative medicine, this is a huge market maybe as big as TECHNOLOGY. From the hardware(tools) to treatments to drugs, now the golden opportunity for those who do some study and digging, a lot have been going on yet a lot more will be happening as the new year unfolds especially in "adult stem cell" area.
Investment in tools, treatments or drugs now is like investment in TECHNOLOGY a decade ago in hardware, software and internet/mobile devices.
Investment in stem cell exectraction/preservat... tools is the safest and the 1st to be rewarded, then treatments and then in drugs. Treatments and drugs will have the biggest winfall but they are further down the pipeline in terms of timing.
Disclosure: long tool stock Thermogenesis(KOOL), lurk on a few stocks in treatment and drug with stem cell/regenerative medicine flavor. KOOL was unjustified beatened at year-end for going under $1. No debt, lots of cash with new products coming as scheduled.
Mike, You need to check on KOOL, it's been awhile. They are shooting to become profitable for the first time next quarter.
Nine for '09 Picks Start Strong [View article]
The next big thing coming is stem cell based regenerative medicine, this is a huge market maybe as big as TECHNOLOGY. From the hardware(tools) to treatments to drugs, now the golden opportunity for those who do some study and digging, a lot have been going on yet a lot more will be happening as the new year unfolds especially in "adult stem cell" area.
Investment in tools, treatments or drugs now is like investment in TECHNOLOGY a decade ago in hardware, software and internet/mobile devices.
Investment in stem cell exectraction/preservat... tools is the safest and the 1st to be rewarded, then treatments and then in drugs. Treatments and drugs will have the biggest winfall but they are further down the pipeline in terms of timing.
Disclosure: long tool stock Thermogenesis(KOOL), lurk on a few stocks in treatment and drug with stem cell/regenerative medicine flavor. KOOL was unjustified beatened at year-end for going under $1. No debt, lots of cash with new products coming as scheduled.
Mike, You need to check on KOOL, it's been awhile. They are shooting to become profitable for the first time next quarter.
Four Stocks for 2009 [View article]
No debt, plenty of cash.
Look at Thermogenesis (KOOL), the leader in cell/stem-cell processing and preservation with no competition.
Tax loss sale has created an once in a life time buying opportunity. Do your dd before investing as always.